Medcura, Inc.

SEC filing

Biotechnology · Riverdale, MD

Form D on EDGAR

Amount raised$28.5Msold at filing

Total offering$38.3M$9.7M still open

Investors in the raise174count reported to the SEC

FiledJul 25, 2025first sale Apr 16, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Rich VincentExecutive Officer

Jim BuckDirector, Executive Officer

Larry TiffanyDirector, Executive Officer

Abbas Ardehali, M.D.Director

Matthew Dowling, Ph.DDirector, Executive Officer

Executive officers, directors and promoters as listed on the Form D.